MMC
60
-2
HRL
38
2
INTU
60
-3
AVB
65
-2
AEP
59
-3
LUV
36
7
PYPL
45
-2
LYB
44
-2
HPE
53
2
CTAS
56
-5
MCK
46
-3
CMCSA
52
6
AIZ
71
-2
PSX
42
3
MS
50
-8
MA
65
-4
MRK
53
3
SYY
50
-8
SRE
54
-5
WU
16
2
MMC
60
-2
HRL
38
2
INTU
60
-3
AVB
65
-2
AEP
59
-3
LUV
36
7
PYPL
45
-2
LYB
44
-2
HPE
53
2
CTAS
56
-5
MCK
46
-3
CMCSA
52
6
AIZ
71
-2
PSX
42
3
MS
50
-8
MA
65
-4
MRK
53
3
SYY
50
-8
SRE
54
-5
WU
16
2
Financhill
Back

ALX Oncology Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
42

ALXO
ALX Oncology Holdings

Last Price:
2.18
Seasonality Move:
40.85%
Sell
25

APLS
Apellis Pharmaceuticals

Last Price:
36.70
Seasonality Move:
15.53%
Sell
42
ALX Oncology Holdings (ALXO) is a Sell

Is ALX Oncology Holdings a Buy, Sell or Hold?

  • The current ALX Oncology Holdings [ALXO] share price is $2.18. The Score for ALXO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ALXO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $36.73. The Score for APLS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALXO Stock Price Chart

What is ALX Oncology Holdings's stock price today?

  • The ALX Oncology Holdings share price today is $2.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALXO is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $36.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

ALXO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 34.55 Sell
Chaikin Money Flow: -151020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.08 - 2.48) Sell
Bollinger Bands (100): (2.39 - 12.11) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 45.36 Sell
Chaikin Money Flow: -475428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.98 - 39.8) Sell
Bollinger Bands (100): (36.68 - 42.54) Sell

ALXO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.17 Buy
20-day SMA: 2.22 Sell
50-day SMA: 3.66 Sell
200-day SMA: 10.48 Sell
8-day EMA: 2.17 Buy
20-day EMA: 2.35 Sell
50-day EMA: 3.73 Sell
200-day EMA: 8.03 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.02 Sell
20-day SMA: 38.38 Sell
50-day SMA: 38.01 Sell
200-day SMA: 50.16 Sell
8-day EMA: 36.95 Sell
20-day EMA: 37.71 Sell
50-day EMA: 38.48 Sell
200-day EMA: 45.83 Sell

ALX Oncology Holdings Earnings Growth & ALXO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.24 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.

ALX Oncology Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):